ProfileGDS5678 / 1439524_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 16% 16% 16% 16% 16% 15% 16% 16% 16% 16% 17% 16% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4511617
GSM967853U87-EV human glioblastoma xenograft - Control 22.3974116
GSM967854U87-EV human glioblastoma xenograft - Control 32.3974616
GSM967855U87-EV human glioblastoma xenograft - Control 42.3407216
GSM967856U87-EV human glioblastoma xenograft - Control 52.3475116
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4607416
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3907515
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3814616
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3605416
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3913316
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3837616
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3859217
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3963416
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3876416